Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
$460M |
| 2 |
GE Aerospace
GE
|
$402M |
| 3 |
CELG
Celgene Corp
CELG
|
$381M |
| 4 |
Bristol-Myers Squibb
BMY
|
$379M |
| 5 |
Johnson & Johnson
JNJ
|
$358M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$307M |
| 2 |
Costco
COST
|
$279M |
| 3 |
Lowe's Companies
LOW
|
$273M |
| 4 |
Microsoft
MSFT
|
$243M |
| 5 |
Chevron
CVX
|
$225M |
Sector Composition
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.12% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VeriSign
VRSN
$25.5B
| $1.61B | 1.42% | 7,688,276 +357,400 | +5% | +$74.8M |
|
2
Chipotle Mexican Grill
CMG
$56.5B
| $1.31B | 1.16% | 1,791,499 +331,100 | +23% | +$243M |
|
3
Novo Nordisk
NVO
$251B
| $1.15B | 1.01% | 22,521,916 +1,177,000 | +6% | +$60.1M |
|
4
Palo Alto Networks
PANW
$127B
| $1.03B | 0.91% | 5,074,350 +590,200 | +13% | +$120M |
|
5
Vertex Pharmaceuticals
VRTX
$100B
| $1.02B | 0.9% | 5,555,817 +477,100 | +9% | +$87.5M |
|
|
6
Bristol-Myers Squibb
BMY
$96B
| $939M | 0.83% | 20,698,607 +8,347,432 | +68% | +$379M |
|
7
Gilead Sciences
GILD
$140B
| $861M | 0.76% | 12,740,248 +4,620,000 | +57% | +$312M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $826M | 0.73% | 8,935,785 +4,122,685 | +86% | +$381M |
|
9
Starbucks
SBUX
$100B
| $788M | 0.69% | 9,403,002 -1,670,984 | -15% | -$140M |
|
10
Humana
HUM
$36.5B
| $780M | 0.69% | 2,940,100 -170,900 | -5% | -$45.3M |
|
11
PepsiCo
PEP
$204B
| $774M | 0.68% | 5,900,214 -1,288,300 | -18% | -$169M |
|
12
Duke Energy
DUK
$95.3B
| $743M | 0.65% | 8,419,329 +263,100 | +3% | +$23.2M |
|
13
Align Technology
ALGN
$10.3B
| $695M | 0.61% | 2,537,681 +277,681 | +12% | +$76M |
|
14
Meta Platforms (Facebook)
META
$1.86T
| $661M | 0.58% | 3,423,861 -434,835 | -11% | -$83.9M |
|
15
Domino's
DPZ
$15.6B
| $648M | 0.57% | 2,330,000 -443,500 | -16% | -$123M |
|
|
VMW
16
DELISTED
VMware, Inc
VMW
| $644M | 0.57% | 3,850,311 -732,489 | -16% | -$122M |
|
|
ABMD
17
DELISTED
Abiomed Inc
ABMD
| $633M | 0.56% | 2,431,723 +370,800 | +18% | +$96.6M |
|
18
Petrobras
PBR
$79.9B
| $627M | 0.55% | 40,251,000 +5,532,200 | +16% | +$86.1M |
|
19
GSK
GSK
$79.9B
| $611M | 0.54% | 15,261,781 +989,181 | +7% | +$39.6M |
|
|
20
Johnson & Johnson
JNJ
$427B
| $605M | 0.53% | 4,341,162 +2,572,695 | +145% | +$358M |
|
21
Atlassian
TEAM
$46.6B
| $603M | 0.53% | 4,607,600 +756,100 | +20% | +$98.9M |
|
22
Biogen
BIIB
$19.4B
| $581M | 0.51% | 2,483,077 +851,263 | +52% | +$199M |
|
23
Hershey
HSY
$37.3B
| $568M | 0.5% | 4,240,564 +1,589,800 | +60% | +$213M |
|
24
TSMC
TSM
$1.2T
| $560M | 0.49% | 14,302,152 +5,643,870 | +65% | +$221M |
|
|
25
GE Aerospace
GE
$292B
| $559M | 0.49% | 53,270,354 +38,260,700 | +255% | +$402M |
|